| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Pfeiffer A, Brantl V, Her... |
Psychotomimesis mediated by kappa opiate receptors. |
Science |
1986 |
| Gillman MA |
Nitrous oxide, an opioid addictive agent. Review of the evidence |
Am J Med |
1986 |
| Battaglia G, Brooks BP, K... |
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at v... |
Eur J Pharmacol |
1988 |
| Fujimoto RA, Boxer J, Jac... |
Synthesis, opioid receptor binding profile, and antinociceptive activi... |
J Med Chem |
1989 |
| Paronis CA, Woods JH |
Ventilation in morphine-maintained rhesus monkeys II: Tolerance to the... |
J Pharmacol Exp Ther |
1997 |
| Helsley S, Filipink RA, B... |
The effects of sigma, PCP, and opiate receptor ligands in rats trained... |
Pharmacol Biochem Be... |
1998 |
| Thongpradichote S, Matsum... |
Identification of opioid receptor subtypes in antinociceptive actions ... |
Life Sci |
1998 |
| Yamamoto LT, Horie S, Tak... |
Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl... |
Gen Pharmacol |
1999 |
| Walsh SL, Strain EC, Abre... |
Enadoline, a selective kappa opioid agonist: comparison with butorphan... |
Psychopharmacology (... |
2001 |
| Saller R, Meier R, Brigno... |
The use of silymarin in the treatment of liver diseases. |
Drugs |
2001 |
| Walsh SL, Geter-Douglas B... |
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pha... |
J Pharmacol Exp Ther |
2001 |
| Boyer EW, Shannon M, Hibb... |
Web sites with misinformation about illicit drugs |
New England Journal ... |
2001 |
| Baumann MH, Pablo J, Ali ... |
Comparative neuropharmacology of ibogaine and its O-desmethyl metaboli... |
Alkaloids Chem Biol |
2001 |
| Roth BL, Baner K, Westkae... |
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid... |
Proc Natl Acad Sci U... |
2002 |
| Takayama H, Ishikawa H, K... |
Studies on the synthesis and opioid agonistic activities of mitragynin... |
J Med Chem |
2002 |
| Tsuchiya S, Miyashita S, ... |
Effect of mitragynine, derived from Thai folk medicine, on gastric aci... |
Eur J Pharmacol |
2002 |
| Baker AK, Hoffmann VL, Me... |
Dextromethorphan and ketamine potentiate the antinociceptive effects o... |
Pharmacol Biochem Be... |
2002 |
| Sheffler DJ, Roth BL |
Salvinorin A: the 'magic mint' hallucinogen finds a molecular target i... |
Trends Pharmacol Sci |
2003 |
| Mowry M, Mosher M, Briner... |
Acute physiologic and chronic histologic changes in rats and mice expo... |
J Psychoactive Drugs |
2003 |
| Butelman ER, Harris TJ, K... |
The plant-derived hallucinogen, salvinorin A, produces kappa-opioid ag... |
Psychopharmacology (... |
2003 |
| Baggott MJ, Erowid E, Ero... |
Use of salvia divinorum, an unscheduled hallucinogenic plant: a web-ba... |
Clinical Pharmacolog... |
2004 |
| Chavkin C, Sud S, Jin W, ... |
Salvinorin A, an active component of the hallucinogenic sage salvia di... |
J Pharmacol Exp Ther |
2004 |
| Munro TA, Rizzacasa MA, R... |
Studies toward the pharmacophore of salvinorin A, a potent kappa opioi... |
J Med Chem |
2005 |
| Chen SL, Huang EY, Chow L... |
Dextromethorphan differentially affects opioid antinociception in rats |
Br J Pharmacol |
2005 |
| Lee DY, Karnati VV, He M,... |
Synthesis and in vitro pharmacological studies of new C(2) modified sa... |
Bioorg Med Chem Lett |
2005 |
| Lee DY, Ma Z, Liu-Chen LY... |
New neoclerodane diterpenoids isolated from the leaves of Salvia divin... |
Bioorg Med Chem |
2005 |
| Schmidt MD, Schmidt MS, B... |
Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvin... |
Synapse |
2005 |
| Prisinzano TE |
Psychopharmacology of the hallucinogenic sage Salvia divinorum |
Life Sci |
2005 |
| Capasso R, Borrelli F, Ca... |
The hallucinogenic herb Salvia divinorum and its active ingredient sal... |
Neurogastroenterol M... |
2006 |
| Mori A, Lehmann S, O'Kell... |
Capsaicin, a component of red peppers, inhibits the growth of androgen... |
Cancer Res |
2006 |
| Beynon CM, Sumnall HR, Mc... |
The ability of two commercially available quick test kits to detect dr... |
Addiction |
2006 |
| Butelman ER, Mandau M, Ti... |
Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocr... |
J Pharmacol Exp Ther |
2007 |
| Rothman RB, Murphy DL, Xu... |
Salvinorin A: Allosteric Interactions at the {micro}-Opioid Receptor |
J Pharmacol Exp Ther |
2007 |
| Braida D, Limonta V, Pego... |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... |
Psychopharmacology (... |
2007 |
| Grundmann O, Phipps SM, Z... |
Salvia divinorum and salvinorin A: an update on pharmacology and analy... |
Planta Med |
2007 |
| Munro TA, Duncan KK, Xu W... |
Standard protecting groups create potent and selective kappa opioids: ... |
Bioorg Med Chem |
2008 |
| Babu KM, McCurdy CR, Boye... |
Opioid receptors and legal highs: Salvia divinorum and Kratom |
Clin Toxicol (Phila) |
2008 |
| Hooker JM, Xu Y, Schiffer... |
Pharmacokinetics of the potent hallucinogen, salvinorin A in primates ... |
Neuroimage |
2008 |
| Wang Y, Chen Y, Xu W, Lee... |
2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist... |
J Pharmacol Exp Ther |
2008 |
| Boyer EW, Babu KM, Adkins... |
Self-treatment of opioid withdrawal using kratom (Mitragynia speciosa ... |
Addiction |
2008 |
| Chartoff EH, Potter D, Da... |
Exposure to the Selective kappa-Opioid Receptor Agonist Salvinorin A M... |
Neuropsychopharmacol... |
2008 |
| Baggott MJ, Erowid E, Ero... |
Use patterns and self-reported effects of Salvia divinorum: An interne... |
Drug Alcohol Depend |
2010 |
| Johnson MW, Maclean KA, R... |
Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... |
Drug Alcohol Depend |
2010 |
| Mendelson JE, Coyle JR, L... |
Lack of effect of sublingual salvinorin A, a naturally occurring kappa... |
Psychopharmacology (... |
2011 |
| Potter DN, Damez-Werno D,... |
Repeated Exposure to the kappa-Opioid Receptor Agonist Salvinorin A Mo... |
Biol Psychiatry |
2011 |
| Addy PH |
Acute and post-acute behavioral and psychological effects of salvinori... |
Psychopharmacology (... |
2011 |
| Travis CR, Ray GA, Marlow... |
A Report of Nausea and Vomiting with Discontinuation of Chronic Use of... |
Case Report Med |
2012 |
| Johnson MW, MacLean KA, C... |
Time course of pharmacokinetic and hormonal effects of inhaled high-do... |
J Psychopharmacol |
2016 |
| Kruegel AC, Gassaway MM, ... |
Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloi... |
J Am Chem Soc |
2016 |
| Anderson L, Bell HG, Gilb... |
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bu... |
JMIR Public Health S... |
2017 |
| Cruz A, Domingos S, Galla... |
A unique natural selective kappa-opioid receptor agonist, salvinorin A... |
Phytochemistry |
2017 |
| Millière R |
Looking for the Self: Phenomenology, Neurophysiology and Philosophical... |
Front Hum Neurosci |
2017 |
| Kruegel AC, Grundmann O |
The medicinal chemistry and neuropharmacology of kratom: A preliminary... |
Neuropharmacology |
2017 |
| Hesselink JMK |
Salvia divinorum induces body awareness changes comparable to metamorp... |
Clin Sci Res Rep |
2019 |
